KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
AI steps in to save transplanted kidneys
Disease control Not yet recruitingThis study tests whether artificial intelligence can help doctors choose the right doses of anti-rejection drugs for kidney transplant patients. The goal is to protect the new kidney from damage over time. About 34 adults who have received a kidney transplant will take part. The …
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated May 17, 2026 07:58 UTC
-
New drug could unlock transplants for Hard-to-Match kidney patients
Disease control Not yet recruitingThis study tests if the drug belimumab can help find more compatible donor kidneys for people who are highly sensitized, meaning their immune system is likely to reject many donor organs. About 25 adults waiting for a kidney transplant will receive a short course of belimumab. Re…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated May 17, 2026 07:35 UTC
-
New hope for kidney transplant patients: early rejection treatment trial launches
Disease control Not yet recruitingThis study looks at kidney transplant recipients who develop antibodies against their new kidney without any signs of kidney damage. Researchers want to see if switching to a drug called belatacept, along with standard treatments, can prevent further rejection better than staying…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2, PHASE3 • Sponsor: University Hospital, Rouen • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Stem cell therapy fails to help kidney rejection, raises safety flags
Disease control Not yet recruitingThis study tested whether a patient's own stem cells (MSCs) could help treat chronic active antibody-mediated rejection in kidney transplant recipients. Only 3 patients were treated before the study was stopped early due to serious side effects. The treatment did not improve reje…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated May 04, 2026 16:18 UTC
-
Blood test may spare kidney patients painful biopsies
Knowledge-focused Not yet recruitingThis study watches 600 kidney transplant patients to see if a blood test (TruGraf/TRAC) can safely track organ health and guide medication. Participants give blood samples over 24 months, and doctors check for rejection, kidney function drops, or other issues. The goal is to lear…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Sponsor: Transplant Genomics, Inc. • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC